Latest Capital And Funding News

Paradigm Biopharmaceuticals has drawn the remaining US$2 million available in Tranche 4 of its convertible note facility, adding approximately A$2.8 million to working capital. The funding comes as its fully enrolled Phase 3 knee osteoarthritis trial advances towards interim analysis and top-line results.

Blackpearl Group more than doubled annual recurring revenue to NZ$26.8 million in FY26, but the growth came alongside an NZ$17.8 million loss and a formal material uncertainty over its ability to continue as a going concern. The company says cost reductions, faster cash conversion and its refinanced BNZ facility can support the next phase.

Way2VAT has secured binding commitments for a A$2.109 million placement, giving the fintech capital to fund the next RBC acquisition payment and its e-invoicing expansion. The raise comes at a 29% discount and carries potential further dilution through free-attaching options.

Core Energy Minerals (ASX:CR3) has secured $3.025 million through a discounted share placement to fund drilling and resource definition at its Nova Uranium Project in Namibia’s Erongo province.

Everest Metals has appointed Hall Chadwick as exclusive strategic adviser to explore funding and commercial pathways for its Mt Edon rubidium project, focusing on US and allied market opportunities.

Acorn Capital Investment Fund Limited posted a 35% drop in profit after tax to $6.25 million for FY2026, while its portfolio outperformed the Small Ords benchmark with a 9.8% return. The company declared fully franked dividends of 3.5 cents per share.

Mayfield Childcare has completed a fully subscribed entitlement offer, raising approximately $3 million to support its ongoing operational turnaround.

FireFly Metals has raised approximately A$190 million through institutional and bought deal placements, positioning the company to advance its Green Bay Copper-Gold Project with early works, drilling, and feasibility studies ahead of a mid-2027 investment decision.

Wisr Limited has reported its inaugural full-year Cash NPAT profit of $1.0 million for FY26, driven by a 65% surge in loan originations and a 32% expansion in its loan book, surpassing $1 billion for the first time.

Hawsons Iron Limited has closed its Share Purchase Plan raising $1.23 million through the issuance of 111.82 million shares at $0.011 each, accompanied by free attaching options. Directors contributed $90,000, reinforcing alignment with shareholders.

Xenitra Limited has secured A$1.5 million through a discounted share placement to accelerate growth in higher-margin OTC medicines, FSMP, and tokenised FMCG sales. The capital will fund inventory expansion, supplier fulfilment, and ecommerce activation as the company shifts from low-margin distribution to a diversified healthcare platform.

WAM Strategic Value delivered a 9.5% portfolio gain for FY2026, outpacing the ASX All Ordinaries by 3.8%, and declared a fully franked full-year dividend of 6.5 cents per share, up 8.3%. The company maintained a strong cash position and continued to capitalise on discounted asset opportunities.